Difference between revisions of "HYPERPARATHYROIDISM-PRIMARY, MANAGEMENT"
(Imported from text file) |
(Imported from text file) |
||
| Line 2: | Line 2: | ||
1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas. | 1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas. | ||
<br/> | <br/> | ||
<br/>2. Other indications for surgery | <br/>2. Other indications for surgery | ||
<br/>- CKD stage 3 | <br/>- CKD stage 3 | ||
<br/>- T-score < -2.5 | <br/>- T-score < -2.5 | ||
| Line 10: | Line 10: | ||
<br/>2. Bisphophonates: build bone. | <br/>2. Bisphophonates: build bone. | ||
<br/> | <br/> | ||
<br/>3. Following treatment | <br/>3. Following treatment: do yearly serum calcium, 1-2 yearly bone scans. | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas.
2. Other indications for surgery
- CKD stage 3
- T-score < -2.5
- Z-score < -2.5 in premenopausal women, men < 50 years.
- Age < 50 years.
2. Bisphophonates: build bone.
3. Following treatment: do yearly serum calcium, 1-2 yearly bone scans.
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
